Login to Your Account

U.S. trade rep names the usual suspects; PhRMA adds Australia

By Michael Fitzhugh
Staff Writer

Monday, May 1, 2017

Ongoing market access barriers for U.S. pharma and medical device companies landed India, Canada and Colombia on the U.S. Trade Representative’s annual “Special 301” watch list again.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription